{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:55Z","timestamp":1793121535863,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jocn.2018.04.034","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T17:48:46Z","timestamp":1524246526000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Patient reported feasibility and acceptance of Montreal Cognitive Assessment (MoCA) screening pre- and postoperatively in brain tumour patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Mirjam","family":"Renovanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Reitzug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Scheurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Gr\u00fcninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Coburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.04.034_b0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jocn.2018.04.034_b0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11864-014-0302-8","article-title":"Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients","volume":"15","author":"Armstrong","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jocn.2018.04.034_b0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11060-016-2064-6","article-title":"Cognitive screening in patients with intracranial tumors: validation of the BCSE","volume":"127","author":"Becker","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2018.04.034_b0020","first-page":"40","article-title":"The association between cognitive functioning and health-related quality of life in low-grade glioma patients","volume":"1","author":"Boele","year":"2014","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.jocn.2018.04.034_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuropsychologia.2014.12.025","article-title":"The impact of different aetiologies on the cognitive performance of frontal patients","volume":"68","author":"Cipolotti","year":"2015","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.jocn.2018.04.034_b0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijrobp.2010.05.003","article-title":"Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86\u201372-51","volume":"81","author":"Daniels","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2018.04.034_b0035","first-page":"89","article-title":"Neurocognitive deficits in patients with malignant brain tumors","volume":"62","author":"Dinkel","year":"2012","journal-title":"Psychother Psychosom Med Psychol"},{"key":"10.1016\/j.jocn.2018.04.034_b0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/pon.3142","article-title":"Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment","volume":"22","author":"Goebel","year":"2013","journal-title":"Psycho-oncology"},{"key":"10.1016\/j.jocn.2018.04.034_b0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-010-0501-5","article-title":"Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer","volume":"104","author":"Goebel","year":"2011","journal-title":"J Neuro-oncol"},{"key":"10.1016\/j.jocn.2018.04.034_b0050","first-page":"1425","article-title":"Acute stress in patients with brain cancer during primary care","volume":"20","author":"Goebel","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jocn.2018.04.034_b0055","first-page":"1797","article-title":"Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase","volume":"19","author":"Goebel","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jocn.2018.04.034_b0060","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00415-002-0839-5","article-title":"Impact of brain tumour treatment on quality of life","volume":"249","author":"Heimans","year":"2002","journal-title":"J Neurol"},{"issue":"Suppl 4","key":"10.1016\/j.jocn.2018.04.034_b0065","doi-asserted-by":"crossref","first-page":"iv17","DOI":"10.1093\/neuonc\/nos161","article-title":"Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities","volume":"14","author":"Klein","year":"2012","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.jocn.2018.04.034_b0070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(02)11398-5","article-title":"Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study","volume":"360","author":"Klein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2018.04.034_b0075","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdq721","article-title":"Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations","volume":"22","author":"Luckett","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2018.04.034_b0080","first-page":"551","article-title":"Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation","volume":"30","author":"Mehnert","year":"2007","journal-title":"Onkologie"},{"key":"10.1016\/j.jocn.2018.04.034_b0085","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.2005.04.6086","article-title":"Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors","volume":"24","author":"Meyers","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2018.04.034_b0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/neuonc\/5.2.89","article-title":"Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression","volume":"5","author":"Meyers","year":"2003","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.jocn.2018.04.034_b0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.wnl.0000413072.54070.a3","article-title":"Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample","volume":"78","author":"Nasreddine","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.04.034_b0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jocn.2018.04.034_b0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.6004\/jnccn.2003.0031","article-title":"Distress management. Clinical practice guidelines","volume":"1","author":"National Comprehensive Cancer","year":"2003","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jocn.2018.04.034_b0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/neuonc\/nox029","article-title":"The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria","volume":"19","author":"Nayak","year":"2017","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.jocn.2018.04.034_b0115","first-page":"1849","article-title":"Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases","volume":"19","author":"Olson","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jocn.2018.04.034_b0120","first-page":"1273","article-title":"Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases","volume":"16","author":"Olson","year":"2008","journal-title":"Support Care in Cancer"},{"key":"10.1016\/j.jocn.2018.04.034_b0125","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00701-013-1884-9","article-title":"Postsurgical screening for psychosocial disorders in neurooncological patients","volume":"155","author":"Renovanz","year":"2013","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.jocn.2018.04.034_b0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fonc.2015.00060","article-title":"Cognitive screening in brain tumors: short but sensitive enough?","volume":"5","author":"Robinson","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2018.04.034_b0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00434800","article-title":"The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life","volume":"2","author":"Sprangers","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jocn.2018.04.034_b0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ejca.2010.01.012","article-title":"An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients","volume":"46","author":"Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A, Group EQoL, Brain Cancer N, Radiotherapy G","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jocn.2018.04.034_b0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1474-4422(04)00680-5","article-title":"Cognitive deficits in adult patients with brain tumours","volume":"3","author":"Taphoorn","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2018.04.034_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410360111","article-title":"Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy","volume":"36","author":"Taphoorn","year":"1994","journal-title":"Ann Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818300547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818300547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:19:24Z","timestamp":1760822364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818300547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":30,"alternative-id":["S0967586818300547"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.04.034","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient reported feasibility and acceptance of Montreal Cognitive Assessment (MoCA) screening pre- and postoperatively in brain tumour patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}